Eurofins: rasises FY targets

(CercleFinance.com) - Boasting strong momentum from its core businesses and Covid-19 related activities in October and November, Eurofins Scientific has said that it is raising its financial targets for FY 2020.


It now anticipates revenues of 5.3 billion euros, ahead of the 5 billion euros expected previously, with higher adjusted EBITDA of 1.3 billion euros, vs. 1.1 billion euros before, and free cash flow of 700 million euros, vs. 600 million euros.

While the bioanalytical service provider believes that the outlook remains robust ahead of 2021, it is leaving its 2021 and 2022 targets unchanged, given the significant level of uncertainty that remains.


Copyright (c) 2020 CercleFinance.com. All rights reserved.